TGFB1 and glaucoma: Furthermore, the reduction of TGFβ signaling observed in the RGC layer (Fig 5) suggests that ARBs can cross the blood-retinal-barrier to act directly on RGCs, supportive of neuroprotective effects found in animal models of glaucoma [11, 16, 17].